Literature DB >> 15024732

Analysis of the allele-specific expression of the mismatch repair gene MLH1 using a simple DHPLC-Based Method.

Isabelle Tournier1, Grégory Raux, Fréderic Di Fiore, Isabelle Maréchal, Carole Leclerc, Cosette Martin, Qing Wang, Marie-Pierre Buisine, Dominique Stoppa-Lyonnet, Sylviane Olschwang, Thierry Frébourg, Mario Tosi.   

Abstract

Quantitative measures of allele-specific gene expression allow the indirect detection of mutations or sequence variants in regulatory elements or in other non-coding regions that may result in significant physiological or pathological changes of gene expression and may contribute to Mendelian or multifactorial disorders. We have devised a simple method, based on RT-PCR and single nucleotide primer extension (SNuPE) with unlabelled dideoxynucleotides, followed by DHPLC (denaturing high performance liquid chromatography). We established optimal conditions for separation of the extended products corresponding to the alleles of the c.655A>G (p.Ile219Val) SNP, which is the most frequent exonic polymorphism of MLH1. We then genotyped 99 unrelated control subjects and measured the allele-specific MLH1 expression in the 40 heterozygous controls found in this group. This method allowed us to define a narrow range of normal biallelic expression of MLH1, each allele contributing between 44.7% and 55.3% of the total expression. We then measured the allele-specific expression in hereditary nonpolyposis colorectal cancer (HNPCC) patients with MLH1 mRNAs bearing different stop-codon or frame-shift mutations, or in-frame deletions, in order to detect the effects of nonsense-mediated mRNA decay (NMD). Defects that induce mRNA instability were identified unambiguously and the data were consistent with current models of NMD. This study provides a sensitive tool to identify indirectly MLH1 defects that may escape detection in genomic DNA screenings but result in a quantitative change at the mRNA level. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024732     DOI: 10.1002/humu.20008

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

1.  tSNP-based identification of allelic loss of gene expression in a patient with a balanced chromosomal rearrangement.

Authors:  Gregory F Guzauskas; Kennedy Ukadike; Lynn Rimsky; Anand K Srivastava
Journal:  Genomics       Date:  2007-01-22       Impact factor: 5.736

2.  Allele-specific expression of APC in adenomatous polyposis families.

Authors:  Ester Castellsagué; Sara González; Elisabet Guinó; Kristen N Stevens; Ester Borràs; Victoria M Raymond; Conxi Lázaro; Ignacio Blanco; Stephen B Gruber; Gabriel Capellá
Journal:  Gastroenterology       Date:  2010-04-29       Impact factor: 22.682

3.  A novel and rapid method of determining the effect of unclassified MLH1 genetic variants on differential allelic expression.

Authors:  Sheron Perera; Brian Li; Soultana Tsitsikotas; Lily Ramyar; Aaron Pollett; Kara Semotiuk; Bharati Bapat
Journal:  J Mol Diagn       Date:  2010-09-23       Impact factor: 5.568

4.  Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriers.

Authors:  Annegret Müller; Dirk Zielinski; Nicolaus Friedrichs; Barbara Oberschmid; Sabine Merkelbach-Bruse; Hans K Schackert; Markus Linnebacher; Magnus von Knebel Doeberitz; Reinhard Büttner; Josef Rüschoff
Journal:  Virchows Arch       Date:  2008-06-26       Impact factor: 4.064

5.  Anticipation in lynch syndrome: where we are where we go.

Authors:  Cristina Bozzao; Patrizia Lastella; Alessandro Stella
Journal:  Curr Genomics       Date:  2011-11       Impact factor: 2.236

6.  Comparing methods for mapping cis acting polymorphisms using allelic expression ratios.

Authors:  Marion Dawn Teare; Suteeraporn Pinyakorn; James Heighway; Mauro F Santibanez Koref
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

7.  Comparison of nonsense-mediated mRNA decay efficiency in various murine tissues.

Authors:  Almoutassem B Zetoune; Sandra Fontanière; Delphine Magnin; Olga Anczuków; Monique Buisson; Chang X Zhang; Sylvie Mazoyer
Journal:  BMC Genet       Date:  2008-12-05       Impact factor: 2.797

8.  Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation.

Authors:  L de Plater; A Laugé; C Guyader; M-F Poupon; F Assayag; P de Cremoux; A Vincent-Salomon; D Stoppa-Lyonnet; B Sigal-Zafrani; J-J Fontaine; R Brough; C J Lord; A Ashworth; P Cottu; D Decaudin; E Marangoni
Journal:  Br J Cancer       Date:  2010-09-28       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.